Name Date: Pharmacy Education Resources National Intravenous Sterile Training Manual for Pharmacy Technicians TSHP Post-Test

Size: px
Start display at page:

Download "Name Date: Pharmacy Education Resources National Intravenous Sterile Training Manual for Pharmacy Technicians TSHP Post-Test"

Transcription

1 Name Date: Pharmacy Education Resources National Intravenous Sterile Training Manual for Pharmacy Technicians TSHP Post-Test For each of the following questions circle the one most correct answer. (For program credit make sure to mark your answers on the Scan-Tron form.) Only the Scan-Tron form will be graded. See enclosed instructions for completing the Scan-Tron. 1. You have an Rx for Clindamycin 600mg IV q8h. You have a 10ml vial of Clindamycin 150mg/ml. How many ml s will you need to withdraw from the vial to get 1 dose? A. 4 ml C. 6 ml B. 3 ml D. 2 ml E. None of the above 2. You need to reconstitute a 10ml vial of cefuroxime 1.5 gm powder? The directions tell you to add 9.4 ml of sterile water to the powder and the resultant solution will be 150mg/ml. How many ml of the final solution will I need to give the patient a dose of 750 mg? A. 10 ml C. 3.2 ml B. 5 ml D. 2.5 ml E. None of the above 3. What is the percentage strength of a solution that contains Mannitol 50 gm in 1 liter of sterile water? A. 0.05% C. 5% B. 0.5% D. 50% E. None of the above 4. How many grams of Dextrose will you need to prepare 500 ml of a 20% solution? A. 500 grams C. 100 grams B. 200 grams D. None of the above 5. The doctor orders diltiazem 0.25mg/kg over 2 minutes. You have available a 5ml vial of diltiazem 5mg/ml. The patient weighs 212 lbs, how many ml of the drug should be given for this dose? A. 4.8 ml C. 4.7 ml B. 4.9 ml D. 5 ml

2 6. Given Nitroglycerin 25mg in D5W 250ml to be infused over 8 hours? What is the rate in ml/hour the patient will be receiving the drug? A. 30 ml/hr C. 32 ml/hr B. 31 ml/hr D. 33 ml/hr 7. A 500 ml bag of LR infusing at 26 ml/hr will last for how long? A hrs C. 5 hrs B. 19 hrs D. None of the above 8. For question #7 above, how many bags will need to be sent in a 24 hour period? A. 1 bag C. 3 bags B. 2 bags D. 4 bags E. 5 bags 9. You have Pitocin 50 units in D5W 250ml to be infused over 2 hours. What is the rate in ml/hr the patient is receiving the Pitocin? A. 10 ml/ hr C. 100 ml/hr B ml/hr D. 125 ml/hr 10. Rx: Gentamycin 23 mg IVPB Q8H x7 days. Available: Gentamicin 20mg/2ml vials. How many ml s of Gentamicin will be needed for EACH IVPB.? A. 1.0 ml C ml B. 2.3 ml D ml 11. For Question #10 above: How many doses will the patient get during the entire 7 days? A. 3 C. 8 B. 7 D For Question #11 above: How many total ml s will be needed to prepare this drug to be mailed out to the patient for the (7 day) therapy? A. 9.6 ml C ml B ml D. None of the above 13. Order: NS infusing at 155 ml/hr, how many ml s will be infused at the end of 8 hours? A ml C ml B ml D. None of the above

3 14. What is the ratio strength of % A. 1:800 C. 1:80,000 B. 1:8,000 D. 1:800, What is the rate of infusion of in ml/hr for the following IV order: NS with 45,000 Units Heparin/liter. Infuse IV at 6000 units/hour. A. 100 ml/hr C. 134 ml/hr B. 133 ml/hr D. None of the above 16. Determine the drop factor using macrodrip tubing (15 gtts/ml) for 500ml of D5LR over 3 hours. A. 40 gtts/min C. 42 gtts/min B. 44 gtts/min D. None of the above Use the following information to answer questions: You need to prepare a dextrose solution with a final concentration of 38%. You are using three strengths of the same solution to obtain this final product. The strengths you have available are 50%, 70%, and 5%. 17. How many PARTS of the 5% solution will be required? A. 12 parts C. 44 parts B. 33 parts D. 32 parts 18. How many PARTS of the 50% solution will be required? A. 12 parts C. 44 parts B. 33 parts D. 32 parts 19. How many PARTS of the 70% solution will be required? A. 12 parts C. 44 parts B. 33 parts D. 32 parts 20. If the final product is to be a total volume of 1.5 liters how many ml s of the 5% solution will be required? A. 450 ml C. 600 ml B. 540 ml D. 436 ml

4 21. If the final product is to be a total volume of 1.5 liters how many ml s of the 50% solution will be required? A. 450 ml C. 600 ml B. 540 ml D. 436 ml 22. If the final product is to be a total volume of 1.5 liters how many ml s of the 70% solution will be required? A. 450 ml C. 600 ml B. 540 ml D. 436 ml 23. You need to mix 1200 ml of 40% Sorbitol solution (V/V), with 700 ml of 90% Sorbitol (V/V). What is the percentage of the solution (V/V) in the mixture? A % C % B % D % 24. Convert 1:25,000 to a percent strength A. 0.04% C. 0.4% B % D. 4% Use the following information to answer questions 25.to 28. : RX: Ticar 645mg IV Q8H for 5 days. Available: Ticarcillin 3 gram/20ml vial (after reconstituted) 25. How many ml s of Ticarcillin will be needed for each dose? A. 3.4 ml C. 4.3 ml B. 4 ml D. None of the above 26. How many vials of Ticar will be needed if you are preparing a 24 hour supply? A. 1 vial C. 3 vials B. 2 vials D. 4 vials 27. How many mls of Ticar will be needed to prepare the 5 days supply? A. 51 ml C. 60 ml B. 64.5ml D. None of the above 28. If you are shipping the Ticar to the patient for entire 5 day therapy how many Ticar bags will you be shipping? (Each Ticar 645mg IV goes into D5W 50ml) A. 5 bags C. 15 bags B. 10 bags D. 20 bags

5 29. The Buffer/Clean rooms should provide which of the following environments according to USP/NF 797? A. ISO Class 6 C. ISO Class 8 B. ISO Class 7 D. ISO Class The Anteroom Area is required to provide which of the following environments according to USP/NF 797? A. ISO Class 6 C. ISO Class 8 B. ISO Class 7 D. ISO Class According to USP/NF 797 the Critical Area is required to provide which of the following environments? A. ISO Class 6 C. ISO Class 8 B. ISO Class 7 D. ISO Class How often must floors in buffer, clean area, ante-area and segregated compounding areas be cleaned at a minimum? A. Daily C. Every Shift B. Monthly D. Every Week 33. How often must ceilings in buffer, clean area, ante-area and segregated compounding areas be cleaned at a minimum? A. Daily C. Every Shift B. Monthly D. Every Week 34. How often must ISO Class 5 Devices such as hoods, barrier isolators and biological safety cabinets be certified? A. Every month C. Every 6 months B. Every year D. Every 6 weeks 35. How often must evaluation of the environmental quality be performed by measuring/sampling the air quality in a low to medium-risk level area? A. Daily C. Every Shift B. Monthly D. Every Week

6 36. How often must evaluation of the environmental quality be performed by measuring/sampling the air quality in a high-risk level area? A. Daily C. Every Shift B. Monthly D. Every Week 37. Environmental viable air sampling must be performed in all risk levels at locations which are prone to contamination during compounding and other activities, these areas include: A. gowning C. staging B. labeling D. All the above E. Only A and B 38. Which of the following general microbiological growth mediums should be used to support the growth of fungi for high-risk level compounding environments? A. Malt extract C. TSA with lecithin B. Soybean Casein Digest D. None of the above 39. Patient safety requires which of the following dosage forms MUST be STERILE when administered to the patient? A. Injections C. Tissue implants B. Ophthalmic drops D. Irrigations for wounds and body cavities E. All of the above 40. Which part of the horizontal laminar air-flow hood should be cleaned first when performing hood cleaning? A. Hepa filter C. Bottom of the hood B. IV pole D. Side wall 41. Before cleaning the horizontal laminar air-flow hood it should be turned on and let run for how long first? A. 2 hours C. 30 minutes B. 1 hour D. 15 minutes E. 5 minutes

7 42. When working in a biological safety cabinet all aseptic manipulations should be performed at least away from each air intake grill. A. 3 inches C. 5 inches B. 4 inches D. 6 inches E. 8 inches 43. Which of the following is/are advantage(s) that compounding aseptic containment isolators have over horizontal and vertical laminar airflow hoods? A. Minimize the extent of personnel contact and interaction. B. Separate the external environment from the critical site. C. Are not as sensitive to external environments. D. All of the above are advantages. 44. First Air is the air that exits the HEPA filter in a unidirectional air stream that is essentially particle free. 45. When performing fingertip glove sampling using sterile agar plates after personnel have completed the media fill test, sterile 70% isopropyl alcohol should be applied to the gloves prior to performing the sampling. 46. In an ISO Class 7 area what level surface sample colony forming unit (cfu) on a contact plate would require immediate action? A. Greater than 3 C. Greater than 10 B. Greater than 5 D. Greater than In an ISO Class 8 area what level surface sample colony forming unit (cfu) on a contact plate would require immediate action? A. Greater than 3 C. Greater than 10 B. Greater than 5 D. Greater than USP 797 requires that when testing volumes for accuracy in automated compounding devices for parenteral nutrition ml be used for large-volumes. A. 40 ml C. 300 ml B. 150ml D. 500 ml

8 49. USP 797 requires which of the following high-risk level compounded sterile preparations must be prepared using USP NF Sterility Tests <71> before being dispensed or administered. A. Groups > 25 identical individual single dose packages B. Multiple dose vials for administration to multiple patients C. Batches that are exposed for longer than 12 hour at 2 0 to 8 0 D. All of the above must be prepared using USP NF Sterility Tests <71> 50. When preparing a TPN solution containing phosphate and calcium additives, should be added first, then squeeze and agitate the additive port, flush by adding other drugs in between and then add last? A. Calcium, phosphate C. It makes no difference which order B. Phosphate, calcium D. All of the above are correct 51. Alcohols have excellent in vitro germicidal activity against? A. Gram-positive vegetative bacteria B. Gram-negative vegetative bacteria C. Multidrug-resistant pathogens D. Mycobacterium tuberculosis E. All of the above For Questions #52. Thru 56. Match the following gowning and gloving garb in the correct order in which these items should be applied according to the USP/NF 797 Guidelines? 52. Head and/or Facial Hair Covers A. Apply first 53. Nonshedding Gown B. Apply second 54. Shoe Cover C. Apply third 55. Sterile Gloves D. Apply fourth 56. Face Mask E. Apply last 57. The USP/NF 797 states that when carts are being used they can NOT cross over clean zones unless they are cleaned and sanitized before returning to the clean room?

9 58. In which laminar airflow hood is the HEPA filter located at the back of the hood facing the preparer? A. Vertical airflow C. Biological safety cabinet B. Horizontal airflow D. Only A and C E. None of the above 59. The USP/797 requires documentation of refrigerators to ensure the temperature remains between degrees Celsius? A. 2 to 8 C. 6 to 12 B. 4 to 10 D. 8 to 14 E. 10 to 16 For Questions #60. To 63. Match the following compounding examples to the appropriate Risk- Level according to the revised USP 797 guidelines: (Answers can be only be used ONCE) Answers: A. Immediate Use Risk Level C. Medium-Risk Level B. Low Risk Level D. High Risk Level E. None of the Above 60. Using multiple ampules to be transferred into one final sterile container. 61. Only a single transfer from a sterile vial utilizing sterile supplies. 62. Emergency Room Treatments to be used within 1 hour. 63. Sterile ingredients measured/mixed with nonsterile devices before sterilization is peformed. 64. Particulate matter consists of extraneous mobile undissolved particles which include gas bubbles. 65. Which of the following factors Do NOT affect preparation of a sterile pharmaceutical? A. Degree of dilution C. Storage time B. Order of mixing D. Preservatives E. All of the above affect preparation 66. Which of the following would be considered Particulate Matter? A. Paper C. Undissolved chemicals B. Glass D. All of the above

10 67. Most parenteral solutions are slightly acidic with a ph range from 3.5 to? A. 6.2 C. 5.6 B. 6.5 D. 4.5 E When this incompatibility occurs you will see a change in color or production of bubbles. A. Physical C. Therapeutic B. Chemical D. All of the above 69. Which of the following type of solutions should NOT be administered via the intravenous route? A. Suspensions C. Solutions B. Oils D. All of the above E. Only A and B 70. The USP 797 requires that whenever a compounded sterile preparation is exposed to temperatures over the warmest labeled limit or temperatures exceeding 40 C (104 F) for more than hours, these preparations should be discarded. A. 24 hours C. 4 hours B. 8 hours D. 2 hours For questions #71. thru 75. Match the following IV drugs with their correct storage and preparation technique: A. Filter C. Do Not refrigerate B. Protect from light D. Mix in D5W only E. Mix in NS only 71. Unasyn 72. Albumin 73. Amphotericin Liposomal 74. Acyclovir 75. Doxycycline Hyclate 76. When using a syringe which components must always remain STERILE? A. Tip C. Barrell B. Inner core of Plunger D. All of the above E. Only A and B

11 77. Which part of the IV administration set is used to REGULATE the rate of drug infusion? A. Roll clamp C. Spike B. Drip chamber D. Filter vent E. Needle adaptor 78. Elastomeric pumps can be used for which of the following: A. Continuous Wound Infusion C. Infusion of Chemotherapy Meds B. Pain Management Meds D. All of the above E. Only A and B 79. When administering IV solutions less than 50ml/hr to pediatric patients which type of drip chamber should be used? A. Microdrip B. Macrodrip 80. Drugs that have a tendency to oxidize should not be placed in plastic containers such as which of the following? A. Nitroglycerin C. Both A and B B. Hydrochloric Acid D. Neither A or B For Questions 81. Thru 83. Match the following types of filters with the types of substances they are capable of removing: micron filter micron filter micron filter A. Removes only particulate matter B. Removes ALL fungi & most bacteria C. Removes ALL fungi & ALL bacteria D. None of the above 84. Despite its effectiveness against these organisms, alcohols have very poor activity against bacterial spores, protozoan oocysts, and certain nonenveloped (nonlipophilic) viruses. 85. Quaternary ammonium compounds are primarily bacteriostatic and fungistatic, although they are microbicidal against certain organisms at high concentrations.

12 86. Because many containers can explode or warp during sterilization, Remington s advises against using pure saturated steam autoclaves to sterilize the following solutions: A. Small-volume parenterals in glass vials with rubber stoppers B. Large-volume parenterals in glass containers C. Small/large volume parenterals in plastic containers: flexible, semirigid, or rigid D. Prefilled syringes E. All of the above 87. Chlorine dioxide has been used in the widespread treatment of drinking water because it has which of the following: A. low toxicity to humans C. is not mutagenic B. is not carcinogenic D. is not an ozone depleting chemical E. All of the above 88. Which of the following is NOT an advantage of sterilization by irradiation? A. Low measurable residues C. Fewer variables to control B. High chemical reactivity D. All the above are advantages 89. Which of the following references is required in a Pharmacy that compounds sterile pharmaceuticals? A. Handbook on Injectable Drug Products B. Specialty reference text appropriate for the scope of pharmacy services provided C. USP/NF Chapter 797 D. All of the above are required E. Only 2 of the above are required 90. Which of the following antimetabolite drugs used to treat cancer attacks the cell-cycle in the G1-phase? A. Floxuridine C. Fluorouracil B. Fludarabine D. Both A and B E. Both A and C 91.The generic name for the mitotic inhibitor VePesid used to treat testicular neoplasms and lung cancer is: A. Etoposide C. Vincristine B. Vinblastine D. Oncovin

13 92. Which of the following is NOT a hormone used to treat prostatic cancer? A. Leuprolide Acetate C. Testolactone B. Flutamide D. Diethylstibestrol 93. Which of the following is required on a chemotherapy order? A. Patient name, height, weight C. Which cycle number B. Patient diagnosis D. Patient specific chemotherapy protocol E. All of the above 94. All new hazardous drugs must be accompanied with a MSDS sheet that defines the appropriate handling precautions, including: A. Protective equipment C. Proper controls B. Spill management D. All of the above E. Only B and C 95. All new hazardous drug packages must be delivered how? A. Placed in sealed containers C. Stored separate from other inventory B. Labeled with a unique identifier D. All of the above E. Only B and C 96. The proposed USP/NF Chapter 800 personnel competency (training of personnel) shall occur prior to handling or preparing hazardous drugs and each person s technique verified: A. At least every 12 months C. When new equipment is used B. When a new hazardous drug is used D. All of the above E. Only B and C 97. Sterile hazardous drugs must NOT be unpacked from their shipping containers: A. In a positive pressure area C. In sterile compounding areas B. In a negative pressure area D. Only B and C E. Only A and C 98. Cytotoxic waste should be removed from the work area as soon as possible. For low volume areas waste should not be stored for any period longer than. A. 60 days C. 120 days B. 90 days D. 150 days E. 240 days

14 99. When placing the needle back into the reconstituted powder vial, it is best to reinsert the needle back into the original puncture if possible, to prevent leaks It is important to remember that patients who have received multiple doses or courses of chemotherapy may not be able to tolerate a dose calculated on their BSA and might be candidates for a reduced drug dose.

Name Date: Pharmacy Education Resources National Intravenous Training Manual for Pharmacists TSHP Post-Test

Name Date: Pharmacy Education Resources National Intravenous Training Manual for Pharmacists TSHP Post-Test Name Date: Pharmacy Education Resources National Intravenous Training Manual for Pharmacists TSHP Post-Test For each of the following questions circle the one most correct answer. (For program credit make

More information

Nonparenteral medications

Nonparenteral medications Nonparenteral medications Capsules and unscored tablets are rounded to the nearest whole tablet. Scored tablets are rounded to the nearest 1/2 tablet. Liquid medications are rounded to one decimal place

More information

Chapter 11. Preparing and Handling Sterile Products and Hazardous Drugs. Paradigm Publishing, Inc. 1

Chapter 11. Preparing and Handling Sterile Products and Hazardous Drugs. Paradigm Publishing, Inc. 1 Chapter 11 Preparing and Handling Sterile Products and Hazardous Drugs Paradigm Publishing, Inc. 1 Preparing Intravenous Products IV route of administration can be used to Reach therapeutic drug serum

More information

2013 USP Chapter <797> Compliance Survey & Current Practice Standards

2013 USP Chapter <797> Compliance Survey & Current Practice Standards 2013 USP Chapter Compliance Survey & Current Practice Standards Kenneth S. Latta, BS, RPh Gates Healthcare Associates, Inc Hillsborough, NC We Welcome Your Questions You can submit questions throughout

More information

Review calculation procedures for the following:

Review calculation procedures for the following: Review calculation procedures for the following: Convert in the Metric System 1000 mg = 1 gram 1000 ml = 1 liter To convert from grams to mg, move the decimal point 3 places to the right (add zeros to

More information

Sterile Product Preparation for Non-Pharmacy Personnel Dennis Sinclair, R.Ph..

Sterile Product Preparation for Non-Pharmacy Personnel Dennis Sinclair, R.Ph.. Sterile Product Preparation for Non-Pharmacy Personnel Dennis Sinclair, R.Ph.. Objectives Describe the importance of accuracy and use of proper aseptic technique when preparing IV medications. Identify

More information

Media Fill Test Kits. Manufactured by. Making USP <797> compliance easy!

Media Fill Test Kits. Manufactured by. Making USP <797> compliance easy! Media Fill Test Kits Manufactured by Making USP compliance easy! Compliance was never so easy! Microbial Contamination Testing for CSPs Hardy Diagnostics offers all the products you need to easily

More information

Sterile Compounding. Jessica Tagerman, PharmD, Rph

Sterile Compounding. Jessica Tagerman, PharmD, Rph Sterile Compounding Jessica Tagerman, PharmD, Rph What is Sterility? Sterility & Sterile Compounding Sterile = free from bacteria or other living microorganisms; totally clean Sterile compounding is the

More information

2008 ASHP Summer Meeting Seattle, Washington Educational Session Abstracts

2008 ASHP Summer Meeting Seattle, Washington Educational Session Abstracts 2008 ASHP Summer Meeting Seattle, Washington Educational Session Abstracts 116 USP Update 2008 and Personnel-Related Environmental Sampling Trissel, L.A. TriPharma Research, P.O. Box 265, Cashiers,

More information

A step-by-step preparation guide

A step-by-step preparation guide A step-by-step preparation guide For needle and needle-free systems This guide provides detailed instructions on the reconstitution, dilution, and storage of VELETRI. It is intended to be used after your

More information

Pharmacy Instructions for Preparation

Pharmacy Instructions for Preparation MARQIBO (vincristine sulfate LIPOSOME injection) Pharmacy Instructions for Preparation Important Information for Preparation 1 The instructions for the constitution of MARQIBO are provided in each kit.

More information

Within the proportion the two outside numbers are referred to as the extremes. The two inside numbers are referred to as the means.

Within the proportion the two outside numbers are referred to as the extremes. The two inside numbers are referred to as the means. Basic Formulas Speaker: Jana Ogden This lecture will demonstrate the expectations for performing a variety of the more complex calculations. You are expected to refer to your text and complete the designated

More information

MICAFUNGIN MIXING

MICAFUNGIN MIXING 1 1-800-862-2731 MICAFUNGIN MIXING Drug Name: MICAFUNGIN Volume and Rate: over 1 hour Schedule: KEY POINTS: FLUSHING: Saline Micafungin Saline Heparin 1. Always wash your hands with an antibacterial soap

More information

Aseptic Technique and Sterile Compounding

Aseptic Technique and Sterile Compounding Aseptic Technique and Sterile Compounding Chapter 12 1 Introduction Hospital technician crucial responsibility: Proper preparation of parenteral products Contamination must be reduced when preparing parenterals

More information

Compounding Medication Regulations

Compounding Medication Regulations Association of Professors of Dermatology 2016 Annual Meeting Swissôtel, Chicago, IL Compounding Medication Regulations Christopher Bichakjian, MD Professor of Dermatology Comprehensive Cancer Center and

More information

REFERENCES American Society of Health-System Pharmacists. ASHP guidelines on handling hazardous drugs. Am J Health-Syst Pharm. 2006; 63:

REFERENCES American Society of Health-System Pharmacists. ASHP guidelines on handling hazardous drugs. Am J Health-Syst Pharm. 2006; 63: Ordering and Handling Applies To: UNM Hospitals Responsible Department: Pharmacy Revised: 8/2017 Procedure Patient Age Group: ( ) N/A (X) All Ages ( )Newborns ( )Pediatric ( )Adult DESCRIPTION/OVERVIEW

More information

Intravenous Fluid and Drug Therapy

Intravenous Fluid and Drug Therapy 11 Intravenous Fluid and Drug Therapy OUTLINE Overview Direct Intravenous Injections Continuous Intravenous Injections Solution Additives Calculating IV Components as Percentages Calculating IV Flow Rates

More information

USP 800 and Hazardous Medications

USP 800 and Hazardous Medications USP 800 and Hazardous Medications Trung H. Nguyen, PharmD and Alesha Davis, CPhT Dayton VA Medical Center Trung.Nguyen610@va.gov Alesha.Davis@va.gov The speaker has no actual or potential conflict of interest

More information

STERILITY TESTING OF PHARMACEUTICAL PRODUCTS

STERILITY TESTING OF PHARMACEUTICAL PRODUCTS STERILITY TESTING OF PHARMACEUTICAL PRODUCTS Tim Sandle CONTENTS Introduction xiii 1 STERILITY 1 Introduction 1 Sterility 3 Microorganisms and Microbial Growth 5 Types of microorganisms 7 Sterilization

More information

PARENTERAL PREPARATIONS

PARENTERAL PREPARATIONS PARENTERAL PREPARATIONS INTRODUCTION Parenteral (Gk, para enteron, beside the intestine) dosage forms differ from all other drug dosage forms, because they are injected directly into body tissue through

More information

Chapter 64 Administration of Injectable Medications

Chapter 64 Administration of Injectable Medications Chapter 64 Administration of Injectable Medications Injectable Medications Injection or intravenous (IV) infusion More invasive than administration by mouth, rectum, or through the skin Common methods

More information

Helping to protect you from exposure to hazardous drugs

Helping to protect you from exposure to hazardous drugs Helping to protect you from exposure to hazardous drugs Closed system solution: Texium closed male luer and SmartSite needle-free valve products What you can t see can hurt you The risks are well documented

More information

A step-by-step preparation guide

A step-by-step preparation guide A step-by-step preparation guide This guide provides detailed instruction on the reconstitution, dilution, and storage of Veletri (epoprostenol) for Injection. It is intended to be used after your healthcare

More information

Division 1 Introduction to Advanced Prehospital Care

Division 1 Introduction to Advanced Prehospital Care Division 1 Introduction to Advanced Prehospital Care Chapter 7 Intravenous Access and Medication Administration Part 1 Principles and Routes of Medication Administration Topics Aseptic Technique Medication

More information

Biosafety Level 3 (BL3)

Biosafety Level 3 (BL3) Biosafety Level 3 (BL3) NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules (Appendix G-II-C) - April 2016 Biosafety Level 3 (BL3) Biosafety Level 3 is applicable to clinical,

More information

Infection Prevention and Control Annual Education Authored by: Infection Prevention and Control Department

Infection Prevention and Control Annual Education Authored by: Infection Prevention and Control Department Infection Prevention and Control Annual Education 2017 Authored by: Infection Prevention and Control Department Objectives After you complete this Computer-Based Learning (CBL) module, you should be able

More information

Math for Meds. College of Southern Nevada. Practice Problems. Nursing 211

Math for Meds. College of Southern Nevada. Practice Problems. Nursing 211 Math for Meds College of Southern Nevada Nursing 211 Name: Date: Directions: 1. Solve the dosage calculation problems utilizing the method of your choice. 2. Show your work! 3.Divide math out to the thousandth

More information

Intrathecal. By the end of this chapter, you will be able to: Introduction. Chapter 20

Intrathecal. By the end of this chapter, you will be able to: Introduction. Chapter 20 Chapter 20 Intrathecal Preparations By the end of this chapter, you will be able to: l Describe the specific risks with intrathecal cytotoxic products l List five checks that need to be carried out on

More information

SARASOTA MEMORIAL HOSPITAL NURSING PROCEDURE

SARASOTA MEMORIAL HOSPITAL NURSING PROCEDURE SARASOTA MEMORIAL HOSPITAL NURSING PROCEDURE TITLE: ISSUED FOR: INTERMITTENT FLUID AND MEDICATION THERAPY Nursing DATE: REVIEWED: PAGES: RESPONSIBILITY: RN, LPN I, LPN II Per Job Description 03/81 8/09

More information

48 th Annual Meeting. A Review of Pharmacy Calculations for Pharmacy Technicians. Metric System of Measurement. Disclosure. Common Conversions

48 th Annual Meeting. A Review of Pharmacy Calculations for Pharmacy Technicians. Metric System of Measurement. Disclosure. Common Conversions 48 th Annual Meeting A Review of Pharmacy Calculations for Pharmacy Technicians Nina Pavuluri, Ph.D. Navigating the Oceans of Opportunity Metric System of Measurement Base Unit Factor Name Symbol 1 (g,

More information

How to Set Up and Infuse Your TPN

How to Set Up and Infuse Your TPN Page 1 of 10 How to Set Up and Infuse Your TPN Important: Do not change any of the supplies listed here. Keep supplies away from children. Only your home care nurse or persons trained by Fairview Home

More information

STANDARDIZED PROCEDURE REPROGRAMMING AND REFILLING INTRATHECAL BACLOFEN PUMPS and ACCESSING THE CATHETER ACCESS PORT (Adult,Peds)

STANDARDIZED PROCEDURE REPROGRAMMING AND REFILLING INTRATHECAL BACLOFEN PUMPS and ACCESSING THE CATHETER ACCESS PORT (Adult,Peds) I. Definition The purpose of this procedure is to allow the Advanced Health Practitioner (AHP) to reprogram and refill intrathecal Baclofen pumps, as well as access the catheter access port for those AHPs

More information

BRIEFING 1 INJECTIONS INTRODUCTION

BRIEFING 1 INJECTIONS INTRODUCTION BRIEFING 1 Injections, USP 28 page 2201. The United States Pharmacopeia is the coordinating pharmacopeia in the efforts toward international harmonization of the specifications provided in this general

More information

PRESCRIBING INFORMATION. Dextrose Injection USP. (Concentrated Dextrose for Intravenous Administration) 50% (500 mg/ml) Fluid and Nutrient Replenisher

PRESCRIBING INFORMATION. Dextrose Injection USP. (Concentrated Dextrose for Intravenous Administration) 50% (500 mg/ml) Fluid and Nutrient Replenisher PRESCRIBING INFORMATION Dextrose Injection USP (Concentrated Dextrose for Intravenous Administration) 50% (500 mg/ml) Fluid and Nutrient Replenisher Pfizer Canada Inc. 17300 Trans-Canada Highway Kirkland,

More information

ALPROLIX Coagulation Factor IX (Recombinant), Fc Fusion Protein INSTRUCTIONS FOR USE Do not Do not YOUR KIT CONTAINS:

ALPROLIX Coagulation Factor IX (Recombinant), Fc Fusion Protein INSTRUCTIONS FOR USE Do not Do not YOUR KIT CONTAINS: ALPROLIX Coagulation Factor IX (Recombinant), Fc Fusion Protein INSTRUCTIONS FOR USE Read the Instructions for Use before you start using ALPROLIX and each time you get a refill. There may be new information.

More information

Appendix 7: Vaccine presentation, preparation, disposal, and needle-stick recommendations

Appendix 7: Vaccine presentation, preparation, disposal, and needle-stick recommendations Appendix 7: Vaccine presentation, preparation, disposal, and needle-stick recommendations A7.1 Presentation of vaccines Most of the vaccines in current use are supplied in prefilled syringes or vials.

More information

SAFE INJECTION PRACTICES. Barbara J Connell MS,MT(ASCP)SH VP Clinical Services Medline Industries, Inc.

SAFE INJECTION PRACTICES. Barbara J Connell MS,MT(ASCP)SH VP Clinical Services Medline Industries, Inc. SAFE INJECTION PRACTICES Barbara J Connell MS,MT(ASCP)SH VP Clinical Services Medline Industries, Inc. DISCLOSURES»Employee of Medline Industries, Inc.»Opinions expressed are my own and not necessarily

More information

Unidirectional Airflow Smoke Test Protocol

Unidirectional Airflow Smoke Test Protocol Unidirectional Airflow Smoke Test Protocol Persons signing as approvers shall have examined the Unidirectional Airflow Protocol. This approval shall signify that testing of operational parameters is adequate

More information

Chapter 7, Medication Administration Part 1 Principles and Routes of Medication Administration Caution: Administering medications is business Always

Chapter 7, Medication Administration Part 1 Principles and Routes of Medication Administration Caution: Administering medications is business Always 1 3 4 5 6 7 8 9 10 Chapter 7, Medication Administration Part 1 Principles and Routes of Medication Administration Caution: Administering medications is business Always take appropriate Standard measures

More information

1 INJECTIONS INTRODUCTION

1 INJECTIONS INTRODUCTION 1 INJECTIONS INTRODUCTION Parenteral articles are preparations intended for injection through the skin or other external boundary tissue, rather than through the alimentary canal, so that the active substances

More information

Strep-a-Test Twister Test

Strep-a-Test Twister Test Strep-a-Test Twister Test Code: 24524 A rapid test for the qualitative detection of Strep A antigen in throat swab specimens. For professional in vitro diagnostic use only. INTENDED USE The Strep A Twist

More information

GB Translated English of Chinese Standard: GB NATIONAL STANDARD OF THE

GB Translated English of Chinese Standard: GB NATIONAL STANDARD OF THE Translated English of Chinese Standard: GB4789.30-2016 www.chinesestandard.net Buy True-PDF Auto-delivery. Sales@ChineseStandard.net GB NATIONAL STANDARD OF THE PEOPLE S REPUBLIC OF CHINA GB 4789.30-2016

More information

247 CMR BOARD OF REGISTRATION IN PHARMACY

247 CMR BOARD OF REGISTRATION IN PHARMACY 247 CMR 18.00: NON-STERILE COMPOUNDING Section 18.01: Authority and Purpose 18.02: Non-Sterile Compounding Process 18.03: Non-Sterile Compounding Facility 18.04: Non-Sterile Compounding Equipment 18.05:

More information

Instructions for Use. For use with. 10 mg vial

Instructions for Use. For use with. 10 mg vial Instructions for Use For use with 10 mg vial Table of Contents Parts of the ZOMA-Jet 10... 1 Supplies you will need to mix a ZOMACTON 10 mg Vial... 2 Mix a ZOMACTON 10 mg vial... 3 Reset the ZOMA-Jet 10...

More information

Cox College Springfield, MO. Dosage Calculation Competency Level II Practice Sheet STUDENT NAME: DATE: STUDENT I.D. #: ADVISOR:

Cox College Springfield, MO. Dosage Calculation Competency Level II Practice Sheet STUDENT NAME: DATE: STUDENT I.D. #: ADVISOR: Cox College Springfield, MO Dosage Calculation Competency Level II Practice Sheet Updated 4/2015 STUDENT NAME: DATE: / / STUDENT I.D. #: ADVISOR: A 95% must be achieved on the competency exam to progress

More information

Pharmaceuticals and Ambulatory Surgery Centers. Tom Simpleman

Pharmaceuticals and Ambulatory Surgery Centers. Tom Simpleman Pharmaceuticals and Ambulatory Surgery Centers Tom Simpleman Consultant Pharmacist 2014 Rocky Mountain Ambulatory Surgery Center Educational Conference April 10, 2014 Pharmaceuticals and Ambulatory Surgery

More information

Instructions for Use Enbrel (en-brel) (etanercept) for injection, for subcutaneous use Multiple-dose Vial

Instructions for Use Enbrel (en-brel) (etanercept) for injection, for subcutaneous use Multiple-dose Vial Instructions for Use Enbrel (en-brel) (etanercept) for injection, for subcutaneous use Multiple-dose Vial How do I prepare and give an injection with Enbrel multiple-dose vial? A multiple-dose vial contains

More information

SAM HOUSTON STATE UNIVERSITY ENVIRONMENTAL HEALTH, SAFETY & RISK MANAGMENT

SAM HOUSTON STATE UNIVERSITY ENVIRONMENTAL HEALTH, SAFETY & RISK MANAGMENT BLOODBORNE PATHOGENS PROGRAM I. PURPOSE The SHSU Bloodborne Pathogens program ensures SHSU compliance with Occupational Safety and Health (OSHA) Standard, 29 CFR 1910.1030, Blood Borne Pathogens. II. SCOPE

More information

MAKE THE CLEAR CHOICE. IV Products and Accessories Designed to Help Maximize Clinical Performance While Optimizing Savings

MAKE THE CLEAR CHOICE. IV Products and Accessories Designed to Help Maximize Clinical Performance While Optimizing Savings MAKE THE CLEAR CHOICE. IV Products and Accessories Designed to Help Maximize Clinical Performance While Optimizing Savings EXCEPTIONAL QUALITY, PERFORMANCE AND VALUE. Infuse medications and fluids accurately

More information

Chapter 16 IV Flow Rates. Name three reasons why you think a person may need fluid replacement, IV fluids.

Chapter 16 IV Flow Rates. Name three reasons why you think a person may need fluid replacement, IV fluids. Chapter 16 IV Flow Rates Name three reasons why you think a person may need fluid replacement, IV fluids. NPO Dehydration Deliver medication Nutrition Deliver blood products 1 Chapter 16 Intravenous Flow

More information

RECONSTITUTION, DOSING AND ADMINISTRATION

RECONSTITUTION, DOSING AND ADMINISTRATION Prescribing Information can be found within this document CORRECT RECONSTITUTION FOR SC AND IV ADMINISTRATION VELCADE (bortezomib) 3.5 mg powder for solution for injection is available for intravenous

More information

6/7/2017 CHANGES IN PHARMA REGULATIONS HOW IT AFFECTS THE OR NURSE DISCLOSURE OBJECTIVES

6/7/2017 CHANGES IN PHARMA REGULATIONS HOW IT AFFECTS THE OR NURSE DISCLOSURE OBJECTIVES CHANGES IN PHARMA REGULATIONS HOW IT AFFECTS THE OR NURSE John Karwoski, RPh, MBA DISCLOSURE I, John Karwoski, RPH, MBA have business relationships with the companies MOBIUS THERAPEUTICS, LLC, Cubex, and

More information

Innovations in Administration and Injection Systems EXPERIENCED CREATIVE FOCUSED

Innovations in Administration and Injection Systems EXPERIENCED CREATIVE FOCUSED Innovations in Administration and Injection Systems EXPERIENCED CREATIVE FOCUSED Meeting Your Drug Administration Challenges Your injectable drug product will be perfectly pure when you ship it, but will

More information

A WHITE PAPER STERILITY TESTING ESSENTIAL THINGS YOU MUST KNOW

A WHITE PAPER STERILITY TESTING ESSENTIAL THINGS YOU MUST KNOW A WHITE PAPER STERILITY TESTING ESSENTIAL THINGS YOU MUST KNOW By Steven G. Richter, Ph.D 1. A WHITE PAPER STERILITY TESTING ESSENTIAL THINGS YOU MUST KNOW (includes combination products) Steven G. Richter

More information

REPACKAGING. APPROVED CONTAINERS

REPACKAGING. APPROVED CONTAINERS REPACKAGING. APPROVED CONTAINERS Working for the World of Tomorrow BOTTLES AGITATE THE PRODUCT BEFORE REPACKAGING The Bottles must fulfill the following requirements: Material: The mouth: The lid: Polyethylene

More information

Chapter 12.0: Test Article Preparation, Accountability, (Pharmacy Manual) and Administration

Chapter 12.0: Test Article Preparation, Accountability, (Pharmacy Manual) and Administration Chapter 12.0: Test Article Preparation, Accountability, (Pharmacy Manual) and Administration Table of Contents: 12.1. Randomization...12-2 12.2. Treatment...12-2 12.3. Drug Supply and Storage...12-2 12.4.

More information

Rapid-VIDITEST. Influenza A+B

Rapid-VIDITEST. Influenza A+B Rapid-VIDITEST Influenza A+B (One step Influenza A+B blister Test for the detection of Influenza type A and type B from nasal swabs, nasal wash or nasal aspirate specimens). Instruction manual Producer:

More information

Pharmaceutical Services Offered in Hospitals

Pharmaceutical Services Offered in Hospitals Pharmaceutical Services Offered in Hospitals Product Services Research Services Teaching Services Support Services Clinical Services In-patients (hospitalized) Out-patients (ambulatory) In-patients (hospitalized)

More information

IMPORTANT DRUG INFORMATION

IMPORTANT DRUG INFORMATION IMPORTANT DRUG INFORMATION 2 nd January 2019 Subject: ERWINAZE Batch 191K Notice of *New* Special Handling Instructions Use a 0.2-micron, low protein binding, in-line filter for IV administration of ERWINAZE

More information

Material Safety Data Sheet CISPLATIN INJECTION SECTION 2 COMPOSITION, INFORMATION ON INGREDIENTS

Material Safety Data Sheet CISPLATIN INJECTION SECTION 2 COMPOSITION, INFORMATION ON INGREDIENTS Material Safety Data Sheet CISPLATIN INJECTION SECTION 1 - PRODUCT MSDS NAME: Cisplatin Injection, BP SYNONYMS: Cis-Diamminedi-chloroplatinum (II) SECTION 2 COMPOSITION, INFORMATION ON INGREDIENTS Active:

More information

Zoledronic Acid Accord 4 mg/5 ml

Zoledronic Acid Accord 4 mg/5 ml Zoledronic Acid Accord 4 mg/5 ml Material Safety Data Sheet 1. Product and Company Identification Product name: Use: Company information Enquiries: Synonyms: Zoledronic Acid Accord 4 mg/5 ml concentrate

More information

Environmental Monitoring in the Cell Processing Laboratory What to do with the data?

Environmental Monitoring in the Cell Processing Laboratory What to do with the data? Environmental Monitoring in the Cell Processing Laboratory What to do with the data? Shelly Heimfeld, Ph.D. Fred Hutchinson Cancer Research Center Seattle Cancer Care Alliance ISCT President Somatic Cell

More information

PART III: CONSUMER INFORMATION

PART III: CONSUMER INFORMATION IMPORTANT: PLEASE READ PART III: CONSUMER INFORMATION NiaStase RT (eptacog alfa, activated) Activated Recombinant Human Blood Coagulation Factor VII Room Temperature Stable This leaflet is Part III of

More information

DRAFT PROPOSAL FOR REVISION OF GENERAL MONOGRAPHS: PARENTERAL PREPARATIONS. (July 2012) Draft for comment

DRAFT PROPOSAL FOR REVISION OF GENERAL MONOGRAPHS: PARENTERAL PREPARATIONS. (July 2012) Draft for comment 1 2 3 4 5 DRAFT PROPOSAL FOR REVISION OF July 2012 RESTRICTED GENERAL MONOGRAPHS: PARENTERAL PREPARATIONS (July 2012) Draft for comment This document was provided by a quality control expert. Should you

More information

TIP NO AEROSOLIZED DRUGS TECHNICAL INFORMATION PAPER NO PURPOSE.

TIP NO AEROSOLIZED DRUGS TECHNICAL INFORMATION PAPER NO PURPOSE. AEROSOLIZED DRUGS TECHNICAL INFORMATION PAPER NO. 56-088-0618 PURPOSE. Healthcare workers risk exposure to exhaled aerosolized drugs along with infectious airborne pathogens during administration and routine

More information

Massage to support. Postnatal 11/11/2014. Infection Control 2013 in your Massage Practice. Monica Pasinato-Forchielli

Massage to support. Postnatal 11/11/2014. Infection Control 2013 in your Massage Practice. Monica Pasinato-Forchielli Massage to support World Pregnancy, Massage Conference Birth Presents: and Postnatal The Down for mother & Dirty and baby on World Sanitation Massage and Conference June Infection Control 2013 in your

More information

SAFETY DATA SHEET Balance Stress and Dehydration Aid

SAFETY DATA SHEET Balance Stress and Dehydration Aid Aurora Pharmaceutical, LLC SAFETY DATA SHEET Balance Stress and Dehydration Aid 1. PRODUCT IDENTIFICATION Product Code: 15-077 Product Name: Balance Stress and Dehydration Aid Product Use: For metabolic

More information

Course Syllabus National College of Midwifery /2017

Course Syllabus National College of Midwifery /2017 Course Title: Intrapartum IV Therapy Credits: 0 Course Description: This course covers the indications for IV therapy in labor and delivery, procedures for establishing, administering, and discontinuing

More information

Environmental Health & Safety Policy Manual

Environmental Health & Safety Policy Manual Environmental Health & Safety Policy Manual Issue Date: 5/31/2017 Policy # EHS-400.17 Isoflurane Use and Exposure Control Procedures 1.0 PURPOSE: LSUHSC is committed to keeping all exposures to hazardous

More information

Standard operating procedures for preparation and administration of intramuscular injections. No Action Rationale

Standard operating procedures for preparation and administration of intramuscular injections. No Action Rationale Standard operating procedures for preparation and administration of intramuscular injections Preparation Overview No Action Rationale 1 Collect and check all equipment 2 Check that the packaging of all

More information

British Columbia Cancer Agency

British Columbia Cancer Agency Page 1 of 12 A. SCOPE This Policy covers the preparation, administration, and disposal of hazardous drugs. See Cancer Drug Manual Appendix 5 for the Hazardous Drug List. (www.bccancer.bc.ca/hpi/drugdatabase/appendices)

More information

Protn-Latex. For Determination of Protein in Latex. (Cat. # Latex, Latex) think proteins! think G-Biosciences

Protn-Latex. For Determination of Protein in Latex. (Cat. # Latex, Latex) think proteins! think G-Biosciences 415PR-02 G-Biosciences 1-800-628-7730 1-314-991-6034 technical@gbiosciences.com A Geno Technology, Inc. (USA) brand name Protn-Latex For Determination of Protein in Latex (Cat. # 786-20Latex, 786-21Latex)

More information

LUPIN LIMITED SAFETY DATA SHEET

LUPIN LIMITED SAFETY DATA SHEET LUPIN LIMITED SAFETY DATA SHEET Section 1: Identification Section 1, Identification Material Manufacturer Distributor Doxycycline Capsules USP 50 mg, 75 mg and 100 mg Lupin Limited Goa - 403722 India Lupin

More information

How Do You Know If a Sterilized Package Remains Sterile?

How Do You Know If a Sterilized Package Remains Sterile? How Do You Know If a Sterilized Package Remains Sterile? 1 Acknowledgments Bioaerosol and Applied Microbiology Team Brian Heimbuch, MS Group Lead Del Harnish, MS Lead Technical Mike McDonald, MS Lead Engineer

More information

Policy Title: Single-Use (Disposable) Devices Policy Number: 13. Effective Date: 6/10/2013 Review Date: 6/10/2016

Policy Title: Single-Use (Disposable) Devices Policy Number: 13. Effective Date: 6/10/2013 Review Date: 6/10/2016 Policy Title: Single-Use (Disposable) Devices Policy Number: 13 5. ROLES AND RESPONSIBILITIES: 5.1. All dental healthcare personnel have responsibility to conform and respect all aspects of this policy.

More information

To detect antibodies to Avian Influenza (AI) using the haemagglutination inhibition test in avian serum specimens 2.

To detect antibodies to Avian Influenza (AI) using the haemagglutination inhibition test in avian serum specimens 2. SADC Harmonized SOP for Avian Influenza HA and HI Serological Tests Prepared by: Dr. P.V. Makaya, Dr. Joule Kangumba and Ms Delille Wessels Reviewed by Dr. P.V. Makaya 1. Purpose and scope To detect antibodies

More information

Education for Self Administration of Intravenous Therapy HOME IV THERAPY PICC. Portacath

Education for Self Administration of Intravenous Therapy HOME IV THERAPY PICC. Portacath HOME IV THERAPY PICC Portacath Who To contact Cardio-Respiratory Integrated Specialist Services (CRISS) Office hours 0800 1630 hours Ph: 364 0167 Weekends and after hours, phone Christchurch Hospital operator

More information

UNIT I EVOLUTION OF THE PHARMACY

UNIT I EVOLUTION OF THE PHARMACY Contents UNIT I EVOLUTION OF THE PHARMACY........................ 1 Chapter 1 Pharmacy History................................................. 3 Egyptian History 4 Greek Influence 4 British Apothecaries

More information

Material Safety Data Sheet. Mitomycin for Injection

Material Safety Data Sheet. Mitomycin for Injection Material Safety Data Sheet Mitomycin for Injection SECTION 1 - PRODUCT MSDS ME: Mitomycin for Injection SYNONYMS: mitomycin-c SECTION 2 COMPOSITION, INFORMATION ON INGREDIENTS ACTIVE: Mitomycin ICTIVE:

More information

The Mechanics of the Dental Anesthetic Cartridge

The Mechanics of the Dental Anesthetic Cartridge The Mechanics of the Dental Anesthetic Cartridge Sponsored by Pierrel, makers of Orabloc (Articaine hydrochloridre 40mg/ml and epinephrine Injection) Abstract Local anesthesia is the fundamental part of

More information

Biosafety in the Animal Setting. Tina Bogac Institutional Biosafety Officer

Biosafety in the Animal Setting. Tina Bogac Institutional Biosafety Officer Biosafety in the Animal Setting Tina Bogac Institutional Biosafety Officer May 27, 2009 Biohazards and Biosafety Risk groups/risk assessment Biosafety/animal biosafety levels Essential work practices Biosafety

More information

BLOOD CULTURE SPECIMEN COLLECTION. Skills: 40 points. Objectives:

BLOOD CULTURE SPECIMEN COLLECTION. Skills: 40 points. Objectives: EXERCISE 7: BLOOD CULTURE SPECIMEN COLLECTION Skills: 40 points Objectives: 1. Differentiate between sterile and antiseptic techniques. 2. Define the following terms: FUO, septicemia, bacteremia, aerobic

More information

PHARMACY DOSING AND ORDERING GUIDE

PHARMACY DOSING AND ORDERING GUIDE PHARMACY DOSING AND ORDERING GUIDE FIRST AND ONLY APPROVED TREATMENT FOR PATIENTS WITH VOD WITH RENAL OR PULMONARY DYSFUNCTION POST HSCT VOD=veno-occlusive disease Indication Defitelio (defibrotide sodium)

More information

MEDICAL WASTE MANAGEMENT PLAN

MEDICAL WASTE MANAGEMENT PLAN Ventura County Environmental Health Division 800 S. Victoria Ave., Ventura CA 93009-1730 TELEPHONE: 805/477-7110 FAX: 805/477-1595 Internet Web Site Address: www.vcrma.org/medical-waste-program MEDICAL

More information

ANTIBODY SCREENING by Uni-Gold Recombigen HIV

ANTIBODY SCREENING by Uni-Gold Recombigen HIV ANTI-HIV SPECIMEN 1 REQUIREMENTS ANTIBODY SCREENING by Uni-Gold Recombigen HIV PRINCIPLE: The Uni-Gold Recombigen HIV was designed as a rapid immunoassay and is intended to detect antibodies to HIV- 1

More information

Part 1 Principles and Routes of Medication Administration

Part 1 Principles and Routes of Medication Administration 1 Chapter 7, Medication Administration Part 1 Principles and Routes of Medication Administration 2 Caution: Administering medications is business Always take appropriate Standard measures to reduce your

More information

For the use of only Oncologist or a Cancer Hospital or a laboratory Doxorubicin Hydrochloride Liposome Injection 2 mg/ml KEMODOXA

For the use of only Oncologist or a Cancer Hospital or a laboratory Doxorubicin Hydrochloride Liposome Injection 2 mg/ml KEMODOXA For the use of only Oncologist or a Cancer Hospital or a laboratory Doxorubicin Hydrochloride Liposome Injection 2 mg/ml KEMODOXA COMPOSITION Each ml contains: Doxorubicin Hydrochloride IP...2 mg Water

More information

Emergency Telephone (800) Mitoxantrone Injection, USP (Concentrate) Mitoxantrone Hydrochloride Antineoplastic

Emergency Telephone (800) Mitoxantrone Injection, USP (Concentrate) Mitoxantrone Hydrochloride Antineoplastic MATERIAL SAFETY DATA SHEET SECTION 1 - PRODUCT & COMPANY IDENTIFICATION 1501 East Woodfield Road Suite 300 East Schaumburg, IL 60173 (847) 969-2700 Product Identifier: Chemical Name: Category: Emergency

More information

Biosafety Level 2 Standard Practices and Containment Office of Research Safety Affairs

Biosafety Level 2 Standard Practices and Containment Office of Research Safety Affairs Biosafety Level 2 Standard Practices and Containment Office of Research Safety Affairs Purpose and Objectives Purpose To promote the safe conduct of research with biohazardous materials known to present

More information

Improving Patient Safety and Compliance

Improving Patient Safety and Compliance Improving Patient Safety and Compliance Module 4 Includes Recommended Procedures Table of Contents Section A... 1 A.1 Intrathecal (IT) Doses... 1 Section B... 1 B.1 Vinca Alkaloids... 1 Section C... 2

More information

SUBJECT: Management of Human Body Fluids/Waste (Bloodborne Pathogens)

SUBJECT: Management of Human Body Fluids/Waste (Bloodborne Pathogens) Page 1 of 6 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 PURPOSE To establish uniform procedures for the safe management of human body fluids

More information

MATERIAL SAFETY DATA SHEET

MATERIAL SAFETY DATA SHEET 300 Northfield Road Bedford, OH 44146 Telephone: (440) 232-3320 -or- (800) 562-4797 MATERIAL SAFETY DATA SHEET Section I - IDENTITY Common/Trade Name: Methotrexate Injection, USP (25 mg/ml; 2mL, 4mL, 8mL

More information

STANDARD OPERATING PROCEDURE #714 USE OF MPTP IN NHPS

STANDARD OPERATING PROCEDURE #714 USE OF MPTP IN NHPS STANDARD OPERATING PROCEDURE #714 USE OF MPTP IN NHPS 1. PURPOSE This Standard Operating Procedure (SOP) describes the guidelines for the use of 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP) in

More information

Chapter 7 8/23/2016. Asepsis and Infection Control. Asepsis. Asepsis (Cont.) Microorganisms. Infection control and prevention

Chapter 7 8/23/2016. Asepsis and Infection Control. Asepsis. Asepsis (Cont.) Microorganisms. Infection control and prevention Chapter 7 Asepsis and Infection Control All items and derived items 2015, 2011, 2006 by Mosby, Inc., an imprint of Elsevier Inc. All rights reserved. Asepsis Microorganisms Tiny microscopic entities capable

More information

Bloodborne Pathogens. General

Bloodborne Pathogens. General Bloodborne Pathogens General Session Objectives Identify bloodborne pathogens (BBPs) Understand how diseases are transmitted Determine your risk of exposure Protect yourself from exposure through prevention

More information

Education for self administration of intravenous therapy HOME IV THERAPY. 30 minute - Baxter Pump Tobramycin

Education for self administration of intravenous therapy HOME IV THERAPY. 30 minute - Baxter Pump Tobramycin HOME IV THERAPY Tobramycin Tobramycin Check the order on the drug chart This can change when the results from your blood test come through. Your doctor will change the order, if required. A copy of the

More information

02006B 1 vial 02006B 1 vial Store at -20 C. Lyophilized recombinant IL-2

02006B 1 vial 02006B 1 vial Store at -20 C. Lyophilized recombinant IL-2 For detection and measurement of human interleukin 2 Catalog #02006 Catalog #02007 2 Plates 10 Plates Product Description The Human Interleukin 2 (IL-2) ELISA Kit is designed for the quantitative detection

More information

CATHETER ACCESS KIT. For use with Prometra Programmable Infusion Systems

CATHETER ACCESS KIT. For use with Prometra Programmable Infusion Systems CATHETER ACCESS KIT Caution: Federal (USA) Law restricts this device to sale by or on the order of a physician. Table of Contents Contents... 3 Description... 3 Indications... 3 Contraindications... 3

More information

Human Influenza A (Swine Flu) Rapid test

Human Influenza A (Swine Flu) Rapid test Human Influenza A (Swine Flu) Rapid test Cat.No: DTSXY-Z9 Lot. No. (See product label) Size 20T Intended use The Influenza A (Swine Flu) test is a rapid chromatographic immunoassay for the qualitative

More information

SurgiCube Clinical Tests

SurgiCube Clinical Tests The use of the SurgiCube over critical zones and instruments to reduce air-borne contamination at intraocular ophthalmic surgeries Oogartsen Praktijk Delfland, Eye clinic Delft, The Netherlands August

More information